These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
380 related articles for article (PubMed ID: 25741170)
1. Complete remission of advanced hepatocellular carcinoma by radiofrequency ablation after sorafenib therapy. Park JG; Park SY; Lee HW World J Gastroenterol; 2015 Feb; 21(8):2568-72. PubMed ID: 25741170 [TBL] [Abstract][Full Text] [Related]
2. Single administration of Selective Internal Radiation Therapy versus continuous treatment with sorafeNIB in locally advanced hepatocellular carcinoma (SIRveNIB): study protocol for a phase iii randomized controlled trial. Gandhi M; Choo SP; Thng CH; Tan SB; Low AS; Cheow PC; Goh AS; Tay KH; Lo RH; Goh BK; Wong JS; Ng DC; Soo KC; Liew WM; Chow PK; BMC Cancer; 2016 Nov; 16(1):856. PubMed ID: 27821083 [TBL] [Abstract][Full Text] [Related]
3. Combination therapy with sorafenib and radiofrequency ablation for BCLC Stage 0-B1 hepatocellular carcinoma: a multicenter retrospective cohort study. Feng X; Xu R; Du X; Dou K; Qin X; Xu J; Jia W; Wang Z; Zhao H; Yang S; Guo C; Liu T; Ma K Am J Gastroenterol; 2014 Dec; 109(12):1891-9. PubMed ID: 25403366 [TBL] [Abstract][Full Text] [Related]
4. Radioembolisation with yttrium‒90 microspheres versus sorafenib for treatment of advanced hepatocellular carcinoma (SARAH): study protocol for a randomised controlled trial. Vilgrain V; Abdel-Rehim M; Sibert A; Ronot M; Lebtahi R; Castéra L; Chatellier G; Trials; 2014 Dec; 15():474. PubMed ID: 25472660 [TBL] [Abstract][Full Text] [Related]
5. Liver Transplantation After Neoadjuvant Sorafenib Therapy: Preliminary Experience and Literature Review. Golse N; Radenne S; Rode A; Ducerf C; Mabrut JY; Merle P Exp Clin Transplant; 2018 Apr; 16(2):227-236. PubMed ID: 27212671 [TBL] [Abstract][Full Text] [Related]
6. Sorafenib combined with percutaneous radiofrequency ablation for the treatment of medium-sized hepatocellular carcinoma. Kan X; Jing Y; Wan QY; Pan JC; Han M; Yang Y; Zhu M; Wang Q; Liu KH Eur Rev Med Pharmacol Sci; 2015; 19(2):247-55. PubMed ID: 25683938 [TBL] [Abstract][Full Text] [Related]
7. Sorafenib: the gold standard therapy in advanced hepatocellular carcinoma and beyond. Gadaleta-Caldarola G; Divella R; Mazzocca A; Infusino S; Ferraro E; Filippelli G; Daniele A; Sabbà C; Abbate I; Brandi M Future Oncol; 2015; 11(16):2263-6. PubMed ID: 26260805 [No Abstract] [Full Text] [Related]
8. Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial. Bruix J; Takayama T; Mazzaferro V; Chau GY; Yang J; Kudo M; Cai J; Poon RT; Han KH; Tak WY; Lee HC; Song T; Roayaie S; Bolondi L; Lee KS; Makuuchi M; Souza F; Berre MA; Meinhardt G; Llovet JM; Lancet Oncol; 2015 Oct; 16(13):1344-54. PubMed ID: 26361969 [TBL] [Abstract][Full Text] [Related]
9. Complete radiological response after sorafenib treatment for advanced hepato-cellular carcinoma. Elleuch N; Ennaifer R; Romdhane H; Cheikh M; Hefaiedh R; Bougassas W; Ben Nejma H; BelHadj N Tunis Med; 2015 Jun; 93(6):350-2. PubMed ID: 26644095 [TBL] [Abstract][Full Text] [Related]
10. Complete response with sorafenib and transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma. Takano M; Kokudo T; Miyazaki Y; Kageyama Y; Takahashi A; Amikura K; Sakamoto H World J Gastroenterol; 2016 Nov; 22(42):9445-9450. PubMed ID: 27895433 [TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes of patients with advanced hepatocellular carcinoma who achieved complete remission after sorafenib therapy. Park JG Clin Mol Hepatol; 2015 Sep; 21(3):287-94. PubMed ID: 26527250 [TBL] [Abstract][Full Text] [Related]
12. Complete response to sorafenib in a patient with recurrent hepatocellular carcinoma. Huan HB; Lau WY; Xia F; Ma KS; Bie P World J Gastroenterol; 2014 Oct; 20(39):14505-9. PubMed ID: 25339839 [TBL] [Abstract][Full Text] [Related]
13. Complete Remission of Unresectable Hepatocellular Carcinoma After Combined Sorafenib and Adjuvant Yttrium-90 Radioembolization. Lorenzin D; Pravisani R; Leo CA; Bugiantella W; Soardo G; Carnelutti A; Umberto B; Risaliti A Cancer Biother Radiopharm; 2016 Mar; 31(2):65-9. PubMed ID: 26986817 [TBL] [Abstract][Full Text] [Related]
14. Transarterial chemoembolization and sorafenib in patients with intermediate-stage hepatocellular carcinoma: time to enter routine clinical practice? Sacco R; Antonucci M; Bargellini I; Marceglia S; Mismas V; Cabibbo G Future Oncol; 2015; 11(17):2371-3. PubMed ID: 26270206 [No Abstract] [Full Text] [Related]
15. Clinical parameters predictive of outcomes in sorafenib-treated patients with advanced hepatocellular carcinoma. Cho JY; Paik YH; Lim HY; Kim YG; Lim HK; Min YW; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC Liver Int; 2013 Jul; 33(6):950-7. PubMed ID: 23601249 [TBL] [Abstract][Full Text] [Related]
16. Sorafenib in combination with transarterial chemoembolization for the treatment of hepatocellular carcinoma. Geschwind JF; Chapiro J Clin Adv Hematol Oncol; 2016 Aug; 14(8):585-7. PubMed ID: 27487101 [No Abstract] [Full Text] [Related]
17. Clinical outcomes of patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective study of routine clinical practice in multi-institutions. Lee SH; Song IH; Noh R; Kang HY; Kim SB; Ko SY; Lee ES; Kim SH; Lee BS; Kim AN; Chae HB; Kim HS; Lee TH; Kang YW; Lee JD; Lee HY BMC Cancer; 2015 Apr; 15():236. PubMed ID: 25885683 [TBL] [Abstract][Full Text] [Related]
18. Adjuvant sorafenib after heptectomy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma patients. Xia F; Wu LL; Lau WY; Huan HB; Wen XD; Ma KS; Li XW; Bie P World J Gastroenterol; 2016 Jun; 22(23):5384-92. PubMed ID: 27340354 [TBL] [Abstract][Full Text] [Related]
19. Long-term complete response of advanced hepatocellular carcinoma treated with multidisciplinary therapy including reduced dose of sorafenib: case report and review of the literature. Shinoda M; Kishida N; Itano O; Ei S; Ueno A; Kitago M; Abe Y; Hibi T; Yagi H; Masugi Y; Tanabe M; Aiura K; Sakamaoto M; Tanimoto A; Kitagawa Y World J Surg Oncol; 2015 Apr; 13():144. PubMed ID: 25889667 [TBL] [Abstract][Full Text] [Related]
20. Case analysis of complete remission of advanced hepatocellular carcinoma achieved with sorafenib. Liu D; Liu A; Peng J; Hu Y; Feng X Eur J Med Res; 2015 Feb; 20(1):12. PubMed ID: 25649133 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]